Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | FASN | P49327 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.31 |
| ▸ | ACP1 | P24666 | 2/20 | 0.31 |
| ▸ | CDC25B | P30305 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL606501 | 0.74 | AKR1B1 (0.33) | PTPN1 | |
| SCHEMBL606692 | 0.74 | AKR1B1 (0.33) | PTPN1 | |
| SCHEMBL606502 | 0.74 | AKR1B1 (0.33) | PTPN1 | |
| SCHEMBL11160573 | 0.68 | GPR84 (0.39) | PTPN1 | |
| SCHEMBL28490120 | 0.67 | — | — | |
| SCHEMBL603685 | 0.64 | POLB (0.38) | POLBFASNPTPN1 | |
| SCHEMBL6156154 | 0.61 | — | — | |
| SCHEMBL6156821 | 0.61 | — | — | |
| SCHEMBL606836 | 0.61 | POLB (0.38) | POLBFASNPTPN1 | |
| SCHEMBL2320721 | 0.61 | POLB (0.38) | POLBFASNPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110275838-A1 | METHOD FOR OBTAINING CINATRINS C3 AND C1 | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2011-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275838-A1 | METHOD FOR OBTAINING CINATRINS C3 AND C1 | C3AR1, CPA3, CYP21A2 | SIRT2 1902/4885POLB 3519/4885FASN 621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.